Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Phenylketonuria (PKU) - Overview
Phenylketonuria (PKU) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Phenylketonuria (PKU) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Phenylketonuria (PKU) - Companies Involved in Therapeutics Development
Agios Pharmaceuticals Inc
American Gene Technologies Intertiol Inc
APR Applied Pharma Research SA
BioMarin Pharmaceutical Inc
Generation Bio Co
Homology Medicines Inc
MipSalus ApS
Moder Inc
Nestle Health Science SA
Pluvia AS
PTC Therapeutics Inc
Sangamo Therapeutics Inc
SOM Biotech SL
Synlogic Inc
Vera Therapeutics Inc
Phenylketonuria (PKU) - Drug Profiles
AGT-324 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
APROD-031 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biologic for Phenylketonuria - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Phenylketonuria (PKU) - Dormant Projects
Phenylketonuria (PKU) - Discontinued Products
Phenylketonuria (PKU) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Phenylketonuria (PKU), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Phenylketonuria (PKU), H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Phenylketonuria (PKU) - Pipeline by Agios Pharmaceuticals Inc, H2 2020
Phenylketonuria (PKU) - Pipeline by American Gene Technologies International Inc, H2 2020
Phenylketonuria (PKU) - Pipeline by APR Applied Pharma Research SA, H2 2020
Phenylketonuria (PKU) - Pipeline by BioMarin Pharmaceutical Inc, H2 2020
Phenylketonuria (PKU) - Pipeline by Generation Bio Co, H2 2020
Phenylketonuria (PKU) - Pipeline by Homology Medicines Inc, H2 2020
Phenylketonuria (PKU) - Pipeline by MipSalus ApS, H2 2020
Phenylketonuria (PKU) - Pipeline by Moderna Inc, H2 2020
Phenylketonuria (PKU) - Pipeline by Nestle Health Science SA, H2 2020
Phenylketonuria (PKU) - Pipeline by Pluvia AS, H2 2020
Phenylketonuria (PKU) - Pipeline by PTC Therapeutics Inc, H2 2020
Phenylketonuria (PKU) - Pipeline by Sangamo Therapeutics Inc, H2 2020
Phenylketonuria (PKU) - Pipeline by SOM Biotech SL, H2 2020
Phenylketonuria (PKU) - Pipeline by Synlogic Inc, H2 2020
Phenylketonuria (PKU) - Pipeline by Vera Therapeutics Inc, H2 2020
Phenylketonuria (PKU) - Dormant Projects, H2 2020
Phenylketonuria (PKU) - Discontinued Products, H2 2020